Holen Sie sich die Stockscreener-App
1.69
0.00%
0.00
Schlusskurs vom Vortag:
$1.69
Offen:
$1.71
24-Stunden-Volumen:
62,290
Relative Volume:
0.23
Marktkapitalisierung:
$14.89M
Einnahmen:
$9.19M
Nettoeinkommen (Verlust:
$-6.94M
KGV:
-2.032
EPS:
-0.8317
Netto-Cashflow:
$-7.57M
1W Leistung:
+1.20%
1M Leistung:
+3.68%
6M Leistung:
-64.28%
1J Leistung:
-68.48%
1-Tages-Spanne:
$1.63
$1.725
1-Wochen-Bereich:
$1.57
$1.73
52-Wochen-Spanne:
$1.4231
$6.96
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Firmenname
Neuroone Medical Technologies Corp
Sektor
Branche
Telefon
(952) 426-1383
Adresse
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC vs PSNYW, GOODO, SHMD, CHAD, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
4.29 | 773.76M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.37 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.325 | 220.96M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
8.05 | 197.39M | 0 | 0 | 0 | 0.00 |
DWLD
Davis Select Worldwide ETF
|
46.60 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-29 | Herabstufung | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Aktie (NMTC) Neueste Nachrichten
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Australia
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
NeuroOne (NMTC) CFO gets 35,000 options at $1.77 - Stock Titan
NeuroOne (NMTC) grants officer options at $1.77 - Stock Titan
NeuroOne Medical (NMTC) CEO granted 68K stock options - Stock Titan
Neuroone Medical Technologies Corp (NMTC) Key Financial Ratios – Valuation, Profitability & More - Value Research
NeuroOne Expects First StereoCED Revenue in Current Quarter - Minichart
NeuroOne reports successful large-animal StereoCED procedures, expects related revenue in Q4 2026 - TradingView
NeuroOne Medical | 8-K: Current report - Moomoo
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript - The Globe and Mail
JonesTrading Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $8 - Moomoo
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Cal - GuruFocus
Neuroone Medical earnings missed by $0.10, revenue fell short of estimates - Investing.com
NMTC Maintained by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
NeuroOne (NMTC) Earnings Call zum 3. Quartal des Geschäftsjahres 2026: Aufträge steigen um 43 %, Marge erreicht 59,9 % - TradingKey
NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall - Investing.com
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Australia
Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp 3Q FY2026: Revenue $1.97M, EPS $(0.28) — 10-Q Summary - TradingView
Q3 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus
NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9% - TradingView
NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk - Stock Titan
NeuroOne Fiscal Q3 2026 Earnings: Gross Margin Expands as Net Loss Widens - TradingKey
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - Yahoo Finance
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification - Yahoo Finance
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time - finance.yahoo.com
NeuroOne Medical Technologies Corp - tradingkey.com
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform - Yahoo Finance
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Cash Flow - TradingKey
NeuroOne Medical Technologies Corp (NMTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NMTC|NeuroOne Medical Technologies Corp|Price:1.900|Chg%:+0.050 - TradingKey
NMTC|NeuroOne Medical Technologies Corp|Price:1.630|Chg%:+0.080 - TradingKey
AZIO Stock Price and Chart — NASDAQ:AZIO - tradingview.com
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial - Yahoo Finance
Brian and Barbara Pratt disclose 12.5% NeuroOne stake (NASDAQ: NMTC) - Stock Titan
NeuroOne Medical Technologies (NMTC) Brian Pratt reports 1,085,934 shares - Stock Titan
Insider Sell: Mark Christianson Sells 10,000 Shares of NeuroOne Medical Technologies Corp (NMTC) - GuruFocus
NMTC (NMTC) director sells 10,000 shares, retains 20,692 after trade - Stock Titan
NeuroOne Medical Technologies Corp. Hits New 52-Week Low at $2.93 - MarketsMojo
Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June - Investing.com UK
NeuroOne Medical Technologies (NMTC) Weighs on Support After 4.58% DeclineSign of Strength - dars.gov.et
Form 144 NEUROONE MEDICAL TECHNOLOGIES Corp For: 30 June By Investing.com - Investing.com South Africa
[144] NEUROONE MEDICAL TECHNOLOGIES Corp SEC Filing - Stock Titan
NeuroOne(R) Added to Russell Microcap(R) Index - Yahoo Finance
Form DEF 14A Neuroone Medical Technologies Corp For: 26 June By Investing.com - Investing.com South Africa
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Finanzdaten der Neuroone Medical Technologies Corp-Aktie (NMTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neuroone Medical Technologies Corp-Aktie (NMTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Christianson Mark | Market Development Director |
Jun 30 '26 |
Sale |
3.18 |
10,000 |
31,773 |
20,692 |
0.12%
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):